(Q39371481)

11 September 2017

p53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53. (English)

1 reference

11 September 2017

1 reference

2

Michael J Spinella

1 reference

11 September 2017

Joshua C Curtin

1

1 reference

PubMed ID

15674351

11 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

11 September 2017

1 reference

11 September 2017

24

1 reference

11 September 2017

9

1 reference

11 September 2017

1481-1490

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208130

11 September 2017

0 references

cites work

Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

From teratocarcinomas to embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

TP53 family members and human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Retinoids in cancer therapy and chemoprevention: promise meets resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Transcriptional repression mediated by the p53 tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Recent advances in chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Increasing incidence of testicular cancer worldwide: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Transcriptional repression by p53 through direct binding to a novel DNA element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

New directions in testicular cancer; molecular determinants of oncogenesis and treatment success

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Histone deacetylases specifically down-regulate p53-dependent gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Role of the histone deacetylase complex in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Negative control of p53 by Sir2alpha promotes cell survival under stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Deacetylation of p53 modulates its effect on cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Derivation and characterization of retinoid-resistant human embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Decision making by p53: life, death and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Transcription therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Retinoids and their receptors in cancer development and chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in v

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

A sequence element of p53 that determines its susceptibility to viral oncoprotein-targeted degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

7 January 2021

No germline TP53 mutations detected in familial and bilateral testicular cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

7 January 2021

Role of P53 and MDM2 in treatment response of human germ cell tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

7 January 2021

Histone deacetylase inhibitors and anticancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

7 January 2021

Retinoic acid confers resistance to p53-dependent apoptosis in SH-SY5Y neuroblastoma cells by modulating nuclear import of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

7 January 2021

Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208130

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208130

1 reference

PubMed ID

15674351

Dimensions Publication ID

11 September 2017

0 references

1 reference

PubMed ID

15674351